BIO vs CE · rev $2.58B vs rev $10.28B
BIO (BIO) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
BIO currently screens at market cap $0. CE currently screens at market cap $5.92B.
Not investment advice. Open the BIO and CE stock pages for the full models.
Not investment advice.